To investigate factors that influence SPOCK expression, subgroup analyses based on clinical variables were done in all patients enrolled in the UALCAN dataset, suggesting that SPOCK2 expression is correlated with patient’s race, tumor grade, and cancer stage. Here, SPOCK2 is linked to neoplasm.